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Abstract: Many studies have found that cardiovascular deaths mostly occur within a few days of
exposure to heat, whereas cold-related deaths can occur up to 30 days after exposure. We investigated
whether influenza infection could explain the delayed cold effects on ischemic heart diseases (IHD)
as they can trigger IHD. We hypothesized two pathways between cold exposure and IHD: a direct
pathway and an indirect pathway through influenza infection. We created a multi-state model
of the pathways and simulated incidence data to examine the observed delayed patterns in cases.
We conducted cross-correlation and time series analysis with Japanese daily pneumonia and influenza
(P&I) mortality data to help validate our model. Simulations showed the IHD incidence through
the direct pathway occurred mostly within 10 days, while IHD through influenza infection peaked
at 4–6 days, followed by delayed incidences of up to 20–30 days. In the mortality data from Japan,
P&I lagged IHD in cross-correlations. Time series analysis showed strong delayed cold effects in
the older population. There was also a strong delay on intense days of influenza which was more
noticeable in the older population. Influenza can therefore be a plausible explanation for the delayed
association between cold exposure and cardiovascular mortality.
Keywords: cold; temperature; ischemic heart disease; influenza; mortality
1. Introduction
Both extreme high and low temperatures increase the risk of cardiovascular diseases (CVD), but
there is a marked difference in how quickly the events occur. The impacts of extreme heat occur quickly
(1–2 days), whereas the impacts of cold usually remain for up to a month [1,2]. Though many studies
have reported these distinct differences, the cause of the difference has not been investigated in detail.
For cold exposure, mounting observational evidence points to influenza as a trigger of ischemic
heart disease (IHD), as demonstrated by the overlapping seasonal patterns of influenza and IHD [3–5].
The biological mechanisms that potentially explain the link between those diseases is the contribution of
acute respiratory infections to blood coagulation and inflammation in the vasculature [6]. Supported by
physiological reasons, a study reported a risk reduction in IHD after influenza vaccination in a high
risk population [7]. However, the idea has raised questions because the highest CVD mortality occurs
within a few days of cold exposure, but this is not long enough for respiratory infections to develop [8].
Considering the time between infections to manifestations of IHD, it points towards one possible
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mechanism whereby influenza infections play a role in the delayed development of IHD after cold
exposure, which could potentially explain the prominent difference from the rapid heat effects on IHD.
In the present study, we attempted to explore the plausibility of the hypothesis that influenza
infection could act as an intermediate state that causes the delayed cold effects on IHD. Specifically, the
aim of this study is to investigate the hypothesis that there are two routes between cold exposure and
IHD: a direct pathway and an indirect pathway via influenza infection (Figure 1). We refer to these two
routes as primary and secondary IHD, respectively. Since there are few studies done in this context,
the present study was conducted primarily for hypothesis building with theoretical and empirical
evaluations. For comparison we also examined the effect of extreme heat.
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Figure 1. A multi-state competing risk model for influenza infections and IHD mortality or morbidity
incidence. Individuals enter the model after being exposed to cold temperatures. First, individuals
follow one of transition pathways 1 to 3. Those who followed Transition 2 and entered the state of
influenza infections take one of Transitions 4 to 6. The primary IHD occurs when individuals take
Transition 3 directly after cold exposure, whereas the secondary IHD occurs if individuals go through
Transitions 2 and 6.
2. Materials and Methods
The analyses primarily consisted of two components. The first component was a theoretical
evaluation using simulation, and the second was an empirical evaluation using the actual data from
Japan. Each result and consistency in findings between those analyses were examined whether they
support our hypothesis. In following section, we first address the methods of simulation in which
competing risks and multi-state models are briefly introduced in the beginning. Then we describe the
details of the data and analysis methods used for empirical assessments.
2.1. Simulation Using Multi-State Models with Competing Risks
2.1.1. Competing Risks and Multi-State Models
Competing risks occur where multiple and mutually exclusive events occur from one starting
state (i.e., condition) [9]. Often, one type of event is singled out as the event of interest, however more
than one type of events usually play a role in the process of the event development. Those other event
types that may prevent the event of interest from occurring are called competing risks. Competing risks
analysis estimates the probability of the event of interest in the presence of competing risks.
Multi-state models are a type of survival analysis that can incorporate competing risks. They are
useful for time to event data in which individuals start from one initial state and eventually end
up in one or more states. In between, intermediate states can exist and be revisited possibly more
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than once [10–12]. Multi-state models are particularly useful when one is interested in the event that
happens after the non-fatal event (i.e., intermediate state).
Altogether, multi-state models of competing risks have the advantage of reflecting the reality
where individuals are often subjected to more than one event, providing biological insights to the
processes of disease development and recovery over time. The methods also allow estimates of median
time to events and event probabilities [10].
In the present study, we used this method to examine if influenza is an intermediate state that
creates a delayed cold effect on IHD, especially by estimating the time for IHD events via direct
and indirect pathways through influenza infection between cold and IHD. Our multi-state model is
shown in Figure 1. We assume influenza infection and IHD are competing risks as they both can be
impacted by cold exposure but mutually exclusive events. Because not all individuals develop the
diseases, an unaffected state (i.e., remain healthy) was also considered in the transitions after exposed
to cold (Transition 1 to 3 respectively). After influenza infection, one was expected to follow one of
the transitions; recovery to healthy, unrecovered (death), or development of IHD (Transition 4 to 5).
The primary IHD is when the disease development takes the direct route via Transition 3, and the
secondary IHD occurs through the indirect route via Transitions 2 and 6.
2.1.2. Simulation for IHD Morbidity
Simulation adds to our understanding of how competing risks could proceed. In our study, we
simulated each event transition in Figure 1 with the aim of examining how the processes of the direct
and indirect IHD events create the overall delayed effect of cold temperature. If our hypothesis or the
structure of multi-state competing risks model is theoretically correct, simulation will yield the overall
IHD with delays that are consistent with the actually exiting IHD data.
Event times were generated using the exponential distribution as the standard distribution for
competing models with constant event probability [9]. Transition states were estimated using the
multinomial distribution to randomly select competing states. The starting state was an extremely
cold day. In order to simulate event times, the mean event times (i.e., daily probability of events) were
required and thus estimated from previous studies and reports. The mean event times for individuals
to take either one of Transitions 1 to 3 in Figure 1 were estimated based on the health quality study [13]
and the reports of outpatient statistics from the National Federation of Health Insurance Societies
and the Ministry of Health, Labour and Welfare (MHLW) in Japan [14,15]. Based on those previous
publications, the mean rate 0.55 stays healthy (Transition 1) as the rate of the population claims no
health issues. For Transition 2 and 3, the daily probabilities of influenza infection and IHD morbidity
was estimated 0.0104 and 0.000735 respectively based on the actual case reports. The transition from
influenza infections to recovery (Transition 4) had a mean rate of 0.14 (1 event per 7 days) meaning
that the average recovery time from influenza was a week. The times to death (Transition 5) and to
development of IHD from influenza (Transition 6) were estimated based on previous studies [16,17].
To avoid heterogeneity, the studies for the probability estimates were, where possible, from the same
region and time (i.e., targeting February 2012 in Japan). However, due to limited studies, probability
estimates for some transitions required using studies outside the target. In particular, because there are
few studies in regard to the mortality rate from influenza infection to IHD (Transition 6), the estimate
for the event transition alternatively used an IHD morbidity study. The details for all transitions are in
Figure S1 in the Supplementary Material.
For simplicity, we assumed no secondary transmissions of influenza, and that cases contracted
influenza on the first day. We examined a range of assumptions concerning event times and transition
rates. We summarized the simulated data using histograms of daily event numbers and cumulative
risk curves over time. We then compared these plots and summary statistics of median times to the
well-established pattern of the delayed IHD risk in order to assess our hypothesized model.
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2.2. Mortality Data from Japan
2.2.1. Data
Daily nationwide mortality in Japan from 1973 to 2012 for IHD and pneumonia and influenza
(P&I) were obtained from the Japanese MHLW. IHD was classified as the International Classification
of Diseases (ICD)-8 and -9 410–414, and ICD-10 I20–I25; pneumonia as ICD-8 and -9 480–486 and
ICD-10 J12–J18; and influenza as ICD-8 470–474, ICD-9 487, and ICD-10 J10–J11. Though pneumonia
can be caused by different pathogens, several studies have used P&I mortality as a reliable proxy for
influenza activity [18–22]. Age groups of 15–64 years, and 65 or older were used. Temperature data
were obtained from the Japan Meteorological Agency. The daily mean temperature averaged over
the 47 prefectural capitals (for the two prefectures, the closest cities to the capitals) was used in this
analysis. The statistical summaries for IHD and P&I mortality, and mean temperatures are available in
the Supplementary Material (Tables S1 and S2).
2.2.2. Statistical Analysis
Cross-Correlations
Analyses for the data from Japan were conducted with cross-correlations and time series
regression models. First, cross-correlation explored whether the data follows the time-ordering
of events in Figure 1 that hypothesize the intermediate role of influenza infection. A cross-correlation
analysis is a simple but useful method to identify lagged relationships between two time series.
We used the method to identify the associations and time lags among IHD, P&I, and temperature.
The correlations were estimated for warm (April to September) and cold (October to following March)
seasons to look for differences in the delayed association by season. Data after the year 2009 were
excluded in the cross-correlations due to pandemics of a novel influenza virus (H1N1) which created
unusual seasonality.
Time Series Analysis
For in-depth exploration, we investigated the role of influenza infection in associations between
IHD and temperature with time series regression analysis. The analysis examined how the delayed
response of IHD mortality to temperature would be changed by considering P&I mortality. The main
aim of this analysis was to provide empirical estimates of the delayed effects of temperature that
we could then compare with our simulations from the theoretical model (Figure 1). This analysis
used a generalized linear model with a quasi-Poisson distribution allowing for overdispersion, and
distributed lag nonlinear models to examine the delayed and non-linear association (DLNM) [23].
The model is:
Yt „ Poisson pµt, θtq
log pµtq “ DOWt`ICDt ` cbpTMPt´lq ` ns ptime, d f q
`intx pTMPt´l , intense f lu daytq
(1)
where Yt is the daily number of IHD deaths on day t, θ is an overdispersion parameter, DOW is a
categorical variable for day of the week. A categorical variable ICD is to account for the transition
periods from ICD-8 to ICD-10. The periods for the disease classification system were taken into
consideration as the base of disease occurrence could alter due to the different diagnosis coding
(Figure S2 in the Supplementary Material). TMP is mean daily temperature and l is the lag days.
cb pTMPq is a cross-basis function for daily temperature parameterized with natural cubic spline terms
on temperature and the delayed response [24]. Following previous studies in which associations and
delayed effects between IHD mortality and temperature were U-, V-, or J-shaped [25,26], the smooth
function used three equally placed knots for temperature and lag. The lag duration was from 0 to
30 days. ns ptime, d f q is a smooth function of time using natural cubic splines to control for seasonality
and long-term trends in deaths [27]. For this smoothing function on time, three degrees of freedom
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(df) per year was used after conducting sensitivity analyses to select the optimum degrees of freedom
based on Akaike’s Information Criterion (see Figure S3 in the Supplementary Material).
To investigate if the period of the highest influenza season increased the average delay between
low temperatures and IHD mortality, we used the interaction term (intx) between the cross-basis
function of temperature and a dichotomous variable of intense days of influenza (intense days are 1,
otherwise 0). The intense days were defined as days when the number of P&I deaths exceeded the 80th
percentile of the distribution in each epidemic year which starts in October. Since this cut-off point
does not perfectly separate days with and without active influenza transmission, sensitivity analyses
were conducted using cut-offs of the 70th percentile and 90th percentile, but these alternative cut-offs
did not significantly change the results.
The current model (Equation (1)) does not include a variable for intense influenza days because it
was not statistically significant and our focus was not the direct impact of influenza but its combined
role with IHD.
The temperature–flu interaction was tested with an F-test. To visually show the impact of the
interaction we plotted the delayed association between temperature and IHD deaths during intense and
non-intense days. We expected that during intense influenza days the average delayed association with
temperature would be longer as there would be more transitions on the delayed pathway (Figure 1).
All statistical analyses were conducted using the R software version 3.1.1 (R Development Core Team,
Vienna, Austria) [28] with the “DLNM” package to fit the distributed lag non-linear model [24].
3. Results
3.1. Simulation
The simulated distributions of times to primary and secondary (i.e., by influenza infections) IHD
are in Figure 2. The primary IHD observations take place quickly and the majority of cases occur
within 10 days, whereas IHD manifested through influenza infections peak at 4–6 days followed by
delayed cases up to 20–30 days. Though the number of secondary IHD incidence was smaller than
that of primary IHD, the secondary pathway added exponential delays to the total IHD.
The cumulative probability plots (Figure 3) further illustrate the immediate and delayed times of
the two pathways between cold exposure and IHD events. Most secondary IHD occurs by 20 days,
but a few cases linger up to 30 days.
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100,000 people.
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3.2. Japan’s Mortality Data
3.2.1. Cross-Correlations
We assessed cross-correlations up to 30 day lags by age group. The characteristics of the results
were very similar between young (aged 15–64) and aged (65 or older) populations. The results of aged
population are shown in Figure 4. See Figure S4 in the Supplementary Material for ages 15–64.
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(f) mean temperature and IHD deaths in a cold season (October to March).
P&I mortality and mean temperature were inversely correlated, because P&I mortality increases
in winter. P&I mortality lagged mean temperature, but the lag time of the highest correlation was
shorter in the cold season (5 day lag) than the warm season (16 day lag). The lag response for high
IHD mortality occurring after low temperatures was relatively quick (1 or 2 days) in both seasons.
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For associations between IHD and P&I mortalities, the correlations were strong positive (r ě 0.65)
throughout the period as expected from their remarkably similar seasonal patterns. As the lag response
to mean temperature was shorter with IHD morality than P&I mortality, the highest cross-correlations
showed P&I mortality lagged IHD mortality by 6 and 8 days in the cold and warm seasons, respectively.
This pattern of P&I lagging IHD supports our hypothesis of secondary IHD via the intermediate state
of influenza infection can take longer than primary IHD after cold exposure, and thus contributes to
delayed cold effects on IHD.
3.2.2. Time Series Analysis
Associations between IHD mortality and temperature were first assessed without influenza (i.e., no
interaction term in Equation (1)). The relative risks (RRs) for extreme low and high temperatures (0 and
30 ˝C) are in Figure 5. These temperatures are approximately the 0.1 and 99.9 percentile of temperature.
Both extreme temperatures are associated with an immediate increase in risk (approximately up to
5 days) for those aged 15–64 years, whereas for those aged 65 or older only high temperatures show a
similar immediate increase. For the older population, the extreme cold effect had an attenuated risk
over time with delayed impacts until approximately 16 days. There was some mortality displacement
after the initial rise in risk among the older population in April to September. We would not expect a
delayed association during the season as influenza infection is not active in summer, meaning very
few cases travel the secondary route via influenza (Figure 1).
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Figure 5. The estimated delayed effects of extreme temperatures on IHD deaths for population aged
65 years or older and age of 15–64 in Japan, 1973–2012. The red lines show the mean association and
the grey areas are 95% confidence intervals. The plots show the cold effects on (a) aged 65 years or
older; (b) age of 15–64; and the heat effects on (c) aged 65 years or older; (d) age of 15–64.
The empirical patterns in risk shown in Figure 5 are similar to our theoretical patterns in
Figure 2. Our theoretical model of risk decreases gradually to day 30, as does the risk in the elderly.
Our theoretical model has a “bump” in risk at day 3 due to the rise of deaths from the delayed transition.
This peak also appeared in the empirical data when the degrees of freedom for temperature and lag
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were increased to allow a more flexible association (see Figure S5 in the Supplementary Material).
For the younger population the empirical risk of cold is relatively short-lived with the majority
occurring within 10 days (Figure 5). This is similar to our theoretical model with only an immediate
effect of cold exposure (Figure 1), suggesting that the lack of a long delayed effect in the younger
population could be because IHD deaths due to influenza infections are not an important factor.
In order to show the similarity between theoretical and empirical results, the lag response curves for
their estimated risks of cold temperature are provided in Figure S6 in the Supplementary Material.
We added an interaction between temperature and influenza epidemics in order to see whether
this changed the lagged association (Figure 6). The cold effect during intense days of influenza was
more delayed than during non-intense days among the population 65 or older. For the population
aged 15–64 years there was little visual difference in risk by intense and non-intense days, which is
further evidence of the unimportance of influenza infections in the younger population. The F-test to
examine the interactions were statistically significant in both populations, however, the interaction
in the older population (F = 22.00, p < 0.001) explained more variance than the younger population
(F = 3.64, p < 0.001). Comparing these results to our theoretical model (Figure 1), the delay in risk
becomes longer when there are more active influenza transmissions and more transitions to the
influenza infections (Transition 2), although this is not the case for the younger population possibly
because more of them recover (Transition 4).
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4. Discussion
In the simulation results, most primary IHD cases occurred within 10 days whereas the majority
of secondary IHD cases took approximately 20 days (Figure 2). The total time for all IHD cases to occur
was a predominantly exponential decline with delays up to 20–30 days, as similarly observed in many
observational studies [29–31]. The interaction analysis in time series models showed that the effect
of extreme cold temperature on IHD deaths during intense influenza days was more delayed than
non-intense days.
Furthermore, the interaction analysis showed that the risk during non-intense influenza days fell
below the risk of intense days after 5 days among the older population. It illustrated the shifts of the
dominant factor for IHD from cold exposure to influenza infections after the ti e lag. Interestingly, the
time lag also coincided with the approximate maximum time of the occurrence of the majority IHD
cases in the younger population in which influenza did not significa tly change the delayed cold eff ct.
These results are consistent with cold being primarily accountable for the primary IHD in both age
groups, and for the older population, influenza infection creates delayed IHD deaths.
Age as an important modifier is not surprising, considering the vulnerability of aging population
due to underlying age-related risks of cardiovascular disease (e.g., hypertension, diabetes, high level
of serum total cholesterol) [32]. Coagulating agents such as fibrinogen also increased by respiratory
infections cause more chances of arterial thrombogenesis for the elderly than for younger adults [33].
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The time lag that influenza infection rises as the predominant factor for IHD deaths is also worth
noting. In previous observational studies the role of influenza as a confounder of the association
between cardiovascular disease and temperature has not been completely accepted and remains
ambiguous [34,35]. Our result indicated that the impact of influenza might be overshadowed if the
optimal lag timings are not appropriately chosen in time series analyses.
Though these results were exactly what we would expect based on our hypothesis with influenza
as the key intermediate state causing the delays, delayed cold effects on IHD were still observed
even after taking into account influenza infection. One possible reason is that cold in itself may
have delayed impacts. There is incomplete knowledge as to how delayed IHD cases are biologically
explained via cold exposure, but cumulative effects of cold in the development of IHD has been
reported [36]. The other explanation for the delay is unmeasured intermediating effects. Though we
focused on influenza in the present study, other respiratory tract and bacterial infections could also
trigger a systematic inflammatory response that increases the risk of IHD [37]. For a more complete
understanding of the mechanism of the delayed cold effects it would be useful for future studies to
account for these possible factors, but this would require detailed individual data on deaths, including
secondary causes and lengths of stay in hospital prior to death.
There are limitations we need to acknowledge. First, our analysis was conducted with P&I
mortality as a proxy of influenza activity. The actual number of the infected incidence among IHD
cases would have provided more accurate pictures of the impacts of influenza. However, getting
such data is difficult since 30%–50% of influenza cases are non-febrile [38–40]. In addition, as far
as P&I mortality captures the daily variations of influenza among the population in which IHD
cases occur, it is still sufficient to assess the impacts of influenza on IHD in our time series analysis.
Secondly, no time lags of influenza incidences was assumed in the time series analysis although
our hypothesis illustrated influenza infection is on the pathway from cold temperature exposure to
secondary IHD events (Figure 1). Influenza infections on the previous days of IHD events are, however,
highly correlated with the current day’s infections (e.g., correlation is consistently ě0.94 with up
to each previous 14 day), that is, the results are less likely to change even considering time lags of
influenza incidences.
Other important limitations include the underlying assumption for competing risks process
that the risks of events and exposures remain unchanged over time [12], which is rarely true in
reality. For instance, we did not consider secondary transmissions for influenza infections, though
this would likely create more delayed cases. Our competing risks model was a simplified picture of
reality where other events may also be involved, but the model captures the most significant events
in the context of short-term cold effects. Acute respiratory infections and cardiovascular diseases
are responsible for a large proportion of increasing morbidity and mortality in winter, and their
short-term associations with cold exposure are widely recognized from epidemiological evidence and
physiological plausibility [41–43]. There is a limitation in the published studies available which do
not give the perfect information to inform our simulation or provide information on interactions with
age. However, the simulated data provides the best current understanding in the likely course of the
disease occurrence as it was consistent with empirical analysis findings and biologically compelling.
We did not include other factors potentially associated with IHD, in particular air pollution [43,44].
However the role of air pollution as a confounder of temperature is dubious [45].
5. Conclusions
The present study does not convey conclusive casual interpretations since the aim was to examine
the hypothesis with simulation tests and empirical data. However, given the consistent results,
our study highlights the potential role of influenza infections in the delayed cold effect due to
secondary IHD.
The role of cold temperature and influenza infection in IHD deserves further investigation, as
increasing our understanding of the underlying cause of delays of IHD in winter can have large public
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health implications given the high number of winter deaths. Not only is IHD the world’s leading cause
of deaths [46], but the aging population continues to increase globally from 11.7% in 2013 to 21.1%
by 2050 [47]. This study provides some important public health implications: (1) Prevention efforts
for cardiovascular diseases such as reducing age-related risk factors may prevent both primary and
secondary IHD; (2) Prevention of influenza infection may reduce the total burden of cardiovascular
disease; (3) These prevention measures need to be intensified in the elderly population.
Cold temperatures are a much bigger killer than heat [42], and this may worsen if extremely
cold winters become more frequent in some parts of the world [48]. Though heat impacts are often
emphasized in the light of global warming, the future changes in patterns of weather and global
population mean that researchers and governments need to continue to pay attention to the health
risks of low temperatures.
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